SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

12.03.2024 - Company plans to hold a business update conference call in April DENVER, March 12, 2024 (GLOBE NEWSWIRE) - SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial stage medical device company developing proprietary solutions to reduce ... Seite 1

Related Keywords

Eric Schlorff ,Nuwellis Inc ,Drug Administration ,Selective Cytopheretic Device ,Acute Kidney Injury ,Humanitarian Device Exemption ,